Genetic variations associated with the development of MASLD and MASH, such as PNPLA3, TM6SF2, GCKR, MBOAT7, MERTK, and HSD17B13, were initially reviewed. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatohepatitis.